Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug Development
- 1 July 2013
- journal article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 47 (4) , 474-483
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Adaptive Licensing: Taking the Next Step in the Evolution of Drug ApprovalClinical Pharmacology & Therapeutics, 2012
- The critical impact of time discounting on economic incentives to overcome the antibiotic market failureNature Reviews Drug Discovery, 2012
- A flexible blueprint for the future of drug developmentThe Lancet, 2010
- Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemmaNature Reviews Drug Discovery, 2008